Literature DB >> 7570058

Adjuvant chemotherapy for colon and rectal cancer.

C S Fuchs1, R J Mayer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7570058

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  8 in total

1.  Molecular staging estimates occult tumor burden in colorectal cancer.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Adv Clin Chem       Date:  2010       Impact factor: 5.394

2.  Chemotherapy of Colorectal Cancer.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

Review 3.  Molecular staging individualizing cancer management.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  J Surg Oncol       Date:  2012-04-01       Impact factor: 3.454

Review 4.  GUCY2C molecular staging personalizes colorectal cancer patient management.

Authors:  Jian P Gong; Stephanie Schulz; Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2012-06       Impact factor: 2.851

Review 5.  Human antibodies in cancer and autoimmune disease.

Authors:  H J Ditzel
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

6.  Eradication of large colon tumor xenografts by targeted delivery of maytansinoids.

Authors:  C Liu; B M Tadayoni; L A Bourret; K M Mattocks; S M Derr; W C Widdison; N L Kedersha; P D Ariniello; V S Goldmacher; J M Lambert; W A Blättler; R V Chari
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients.

Authors:  Alex Mejia; Stephanie Schulz; Terry Hyslop; David S Weinberg; Scott A Waldman
Journal:  Expert Rev Mol Diagn       Date:  2009-11       Impact factor: 5.225

8.  Is early post-operative treatment with 5-fluorouracil possible without affecting anastomotic strength in the intestine?

Authors:  B M van der Kolk; B M de Man; T Wobbes; T Hendriks
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.